Abstract

The purpose of the proposed trial is to determine if there is a difference in EGFR phosphorylation in bladder epithelium (adjacent normal appearing) 24 hours post-study dose, between patients randomized to erlotinib weekly as compared to placebo.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Station Support Contracts (N03)
Project #
261201200033I-0-26100002-1
Application #
8762943
Study Section
Project Start
2013-09-20
Project End
2016-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$559,231
Indirect Cost

  Institution

Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715